|
|
Terason Ultrasound
Systems have been selected as the screening ultrasound
system for a large joint US-Ukraine-Belarus study project,
directed by Dr. Ihor Masnyk of the National Cancer Institute.
The study is a longitudinal
surveillance project involving a sample population of
over 20,000 that is designed to assess changes (morphologic
and functional) in the thyroid glands of persons exposed
to radioactive materials released as a consequence of
the 1986 Chornobyl Nuclear Power Plant accident. The
study aims to determine the risk coefficient for thyroid
cancer (in relation to dose, sex, and age in 1986),
and assess the relative effectiveness of Iodine-131
with that of x-ray and gamma irradiation in inducing
cancer and other thyroid conditions. The Ukrainian arm
of the study is based in Kiev, at the Institute of Endocrinology
and Metabolism. The Belarus arm is based at the Republican
Research Center of Radiation Medicine and Human Ecology
in Gomel.
To date, the Ukrainian
and Belarusian centers have performed over 5,000 field
exams with the Terason units, storing over 300 Gigabytes
of image data. Physicians have reported that Terason's
ability to store and later review image loops has been
of critical importance when clinical questions arise.
Image quality, portability, and user-friendliness were
major criteria used in selecting the Terason Ultrasound
System. The system has elicited an enthusiastic response
from all of the physicians in the study. According to
Dr. Patrick O'Kane, primary clinical ultrasound expert
from the US arm of the Project, "Terason can certainly
take a bow for providing a unique, state of the art
imaging solution. We have been pleased with the system's
functionality and with Terason's responsiveness and
support service.
For more information, visit:
http://dceg.cancer.gov/chornobylThyroidUkraine.html
back to index
|
|
|
